Mandate

Vinge advises Marvell in conjunction with the acquisition of Xelerated

January 11, 2012

Vinge has advised Marvell Semiconductors Inc., the world leader within semiconductor solutions and quoted on NASDAQ in conjunction with the acquisition of Xelerated, which provides technology solutions for industrial networks. Xelerated’s majority owner is the Sixth AP fund.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Paul Dali and Albert Wållgren. Partner Fredrik Dahl and associate Åsa Gotthardsson provided advice on the employment law aspects of the transaction and partner Mattias Schömer and associate Tora Hansjons provided tax law advice.

Related

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson to Citira, a European tire management provider and portfolio company of Norvestor. Headquartered in Stockholm, Malte Månson is an independent service and repair provider for commercial vehicles and operates a network of 28 service workshop locations across Sweden, authorized by brands such as MAN, DAF, IVECO, Mercedes-Benz, Setra, VDL and EVO. Malte Månson has an annual revenue of SEK 800 million and employs over 300 full-time professionals.
June 08, 2026

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026